It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
STAT+: Pharmalittle: FDA commish calls U.S. drug prices ‘too high’; FDA staff says Eisai and Biogen’s Alzheimer’s drug has benefits
June 8, 2023 Comments Off on STAT+: Pharmalittle: FDA commish calls U.S. drug prices ‘too high’; FDA staff says Eisai and Biogen’s Alzheimer’s drug has benefitsFDA Commissioner Robert Califf told a crowd of biotech leaders at the BIO convention that drug costs needed fixing. Click here to view original post… […]
-
June 8, 2023 Comments Off on Ameresco and Atura Power JV Selected to Build 250MW/1,000MWh Battery Energy Storage System
-
June 8, 2023 Comments Off on Upstream Bio raises $200M in new financing round to get asthma drug to PhIII
-
June 8, 2023 Comments Off on Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
-
June 8, 2023 Comments Off on BIO speakers underscore ‘crucial’ moment for genetic medicines
Popular Articles
-
March 30, 2022 Comments Off on How spirituality can benefit medicine
-
March 31, 2022 Comments Off on Exclusive: Following a severe setback, BridgeBio brings out the budget ax to chop staff but keeps quiet on the numbers
-
March 31, 2022 Comments Off on With pharma still struggling in Alzheimer’s, health tech companies want a swing
-
March 31, 2022 Comments Off on Merck chopping 140-plus staffers out of Acceleron in wake of $11.5B buyout